Improving survival for patients with atrial fibrillation and advanced heart failure (Q57631087)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Improving survival for patients with atrial fibrillation and advanced heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

W G Stevenson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L W Stevenson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

H R Middlekauff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M A Hamilton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M A Woo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L A Saxon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P D Natterson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Steimle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J A Walden

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J H Tillisch

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1458-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Left ventricular function in patients with atrial fibrillation before and after cardioversion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Low-dose amiodarone for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Factors influencing the one-year mortality of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Predictors of sudden death in idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Proarrhythmia in patients treated for atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Improving survival for patients with advanced heart failure: A study of 737 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Risk of arterial embolization in 224 patients awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Alterations in Intracellular Calcium Handling Associated With the Inverse Force-Frequency Relation in Human Dilated Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2896%2900358-0

7 January 2021

10.1016/S0735-1097(96)00358-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917258%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference